Publications

Sonnenberg GF, Monticelli LA, Alenghat T, Fung TC, Hutnick NA, Kunisawa J, Shibata N, Grunberg S, Sinha R, Zahm AM et al..  2012.  Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria.. Science. 336(6086):1321-5.

Hepworth MR, Monticelli LA, Fung TC, Ziegler CGK, Grunberg S, Sinha R, Mantegazza AR, Ma H-L, Crawford A, Angelosanto JM et al..  2013.  Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria.. Nature. 498(7452):113-7.

Kelsen JR, Dawany N, Moran CJ, Petersen B-S, Sarmady M, Sasson A, Pauly-Hubbard H, Martinez A, Maurer K, Soong J et al..  2015.  Exome sequencing analysis reveals variants in primary immunodeficiency genes in patients with very early onset inflammatory bowel disease.. Gastroenterology. 149(6):1415-24.

Wagage S, Pritchard GHarms, Dawson L, Buza EL, Sonnenberg GF, Hunter CA.  2015.  The Group 3 Innate Lymphoid Cell Defect in Aryl Hydrocarbon Receptor Deficient Mice Is Associated with T Cell Hyperactivation during Intestinal Infection.. PLoS One. 10(5):e0128335.

Hepworth MR, Fung TC, Masur SH, Kelsen JR, McConnell FM, Dubrot J, Withers DR, Hugues S, Farrar MA, Reith W et al..  2015.  Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4⁺ T cells.. Science. 348(6238):1031-5.

Kelsen JR, Baldassano RN, Artis D, Sonnenberg GF.  2015.  Maintaining intestinal health: the genetics and immunology of very early onset inflammatory bowel disease.. Cell Mol Gastroenterol Hepatol. 1(5):462-476.

Bessman NJ, Sonnenberg GF.  2016.  Emerging roles for antigen presentation in establishing host-microbiome symbiosis.. Immunol Rev. 272(1):139-50.

Fung TC, Bessman NJ, Hepworth MR, Kumar N, Shibata N, Kobuley D, Wang K, Ziegler CGK, Goc J, Shima T et al..  2016.  Lymphoid-Tissue-Resident Commensal Bacteria Promote Members of the IL-10 Cytokine Family to Establish Mutualism.. Immunity. 44(3):634-46.

Withers DR, Hepworth MR, Wang X, Mackley EC, Halford EE, Dutton EE, Marriott CL, Brucklacher-Waldert V, Veldhoen M, Kelsen J et al..  2016.  Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells.. Nat Med. 22(3):319-23.

Withers DR, Hepworth MR, Wang X, Mackley EC, Halford EE, Dutton EE, Marriott CL, Brucklacher-Waldert V, Veldhoen M, Kelsen J et al..  2016.  Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells.. Nat Med. 22(3):319-23.

J Blander M, Longman RS, Iliev ID, Sonnenberg GF, Artis D.  2017.  Regulation of inflammation by microbiota interactions with the host.. Nat Immunol. 18(8):851-860.

Jacob V, Crawford C, Cohen-Mekelburg S, Viladomiu M, Putzel GG, Schneider Y, Chabouni F, OʼNeil S, Bosworth B, Woo V et al..  2017.  Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.. Inflamm Bowel Dis. 23(6):903-911.

Zhou L, Chu C, Teng F, Bessman NJ, Goc J, Santosa EK, Putzel GG, Kabata H, Kelsen JR, Baldassano RN et al..  2019.  Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2.. Nature. 568(7752):405-409.

Zhou L, Chu C, Teng F, Bessman NJ, Goc J, Santosa EK, Putzel GG, Kabata H, Kelsen JR, Baldassano RN et al..  2019.  Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2.. Nature. 568(7752):405-409.

Petersen TH, Jee MH, Gadsbøll A-SØ, Schmidt JD, Sloth JJ, Sonnenberg GF, Geisler C, Thyssen JP, Bonefeld CM.  2019.  Mice with epidermal filaggrin deficiency show increased immune reactivity to nickel.. Contact Dermatitis. 80(3):139-148.

Bessman NJ, Mathieu JRR, Renassia C, Zhou L, Fung TC, Fernandez KC, Austin C, Moeller JB, Zumerle S, Louis S et al..  2020.  Dendritic cell-derived hepcidin sequesters iron from the microbiota to promote mucosal healing.. Science. 368(6487):186-189.

Goc J, Lv M, Bessman NJ, Flamar A-L, Sahota S, Suzuki H, Teng F, Putzel GG, Eberl G, Withers DR et al..  2021.  Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer.. Cell. 184(19):5015-5030.e16.